BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Report Library

All Reports
Datamonitor Healthcare Other: Uterine Fibroids Market Spotlight

Retail Price: $2,995.00

*BioMedTracker Subscriber Price: $2,095.00 - click here to log in

June 18, 2018

Uterine fibroids, also known as leiomyomas or myomas, are the most common type of benign uterine neoplasms in women of childbearing age. They are a major cause of morbidity in women of this age range, and occasionally also after menopause. Uterine fibroids are the monoclonal neoplasms of uterine smooth muscle cells, with the neoplasms consisting of sizable amounts of extracellular matrix, containing fibronectin, collagen, and proteoglycan. Although the pathogenesis of uterine fibroids is not clearly known, evidence suggests that progestogens and estrogens proliferate growth of the tumor, as the fibroids rarely develop before menarche and relapse after menopause.

This Datamonitor Healthcare report contains a Market Spotlight module.

Disease Group Covered: Obstetrics/Gynecology
Back to the top Back to the top